FDA Brief

Warning letters Drugs

FDA warning letter to

pharmahealthonline.com

High riskIssued Jan 6, 2023Posted Jan 10, 2023Center for Drug Evaluation and Research | CDER

FDA warned pharmahealthonline.com for selling unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers online.

What happened

FDA reviewed the website www.pharmahealthonline.com and found it offered unapproved and misbranded opioid and benzodiazepine drugs to U.S. consumers. Examples included tramadol marketed as “JPDOL-100,” alprazolam marketed as “Ksalol 1mg,” and clonazepam marketed as “Rivotril 2mg.” FDA found this by reviewing the website, not through an inspection.

What FDA found

  1. The website sells tramadol, alprazolam, and clonazepam that are not approved by FDA.

    21 U.S.C. § 355(a); FD&C Act § 505(a)
  2. Selling these unapproved new drugs in interstate commerce violates the FD&C Act.

    21 U.S.C. § 331(d); FD&C Act § 301(d)
  3. The drug labeling lacks adequate directions for a layperson to use them safely.

    21 U.S.C. § 352(f)(1); FD&C Act § 502(f)(1)
  4. Offering these misbranded drugs for sale causes them to be introduced into interstate commerce.

    21 U.S.C. § 331(a); FD&C Act § 301(a)

What FDA wants

FDA asks the company to stop offering any unapproved and misbranded drugs to U.S. consumers and to respond in writing within 15 working days with corrective steps and documentation.

Who should pay attention

  • online pharmacies selling to U.S. consumers
  • companies sourcing or reselling opioid or benzodiazepine products
  • payment and shipping services supporting online drug sales

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk